• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

左炔诺孕酮宫内节育器的五年使用经验。

Five years' experience with levonorgestrel-releasing IUDs.

作者信息

Luukkainen T, Allonen H, Haukkamaa M, Lähteenmäki P, Nilsson C G, Toivonen J

出版信息

Contraception. 1986 Feb;33(2):139-48. doi: 10.1016/0010-7824(86)90080-6.

DOI:10.1016/0010-7824(86)90080-6
PMID:3084167
Abstract

Two levonorgestrel-releasing IUDs and a copper-releasing IUD of the same shape were studied in a randomized comparative study over five years. The levonorgestrel-releasing IUDs released 20 micrograms or 30 micrograms per day. The Pearl index during the 10,600 woman-months of LNG-IUD use was 0.11. The control device releasing copper had a Pearl index of 1.6. The amount and duration of menstrual bleeding was greatly reduced, leading to a high incidence of oligo- or amenorrhea. The continuation rate in this pioneer trial was 53 per 100 users for the levonorgestrel-releasing IUD (LNG-IUDs) and 50 per 100 users for the copper-releasing IUD (Nova T). The removal rates for reasons other than amenorrhea were not significantly different. Discontinuation because of amenorrhea occurred during the first two years, the cumulative termination rate for this reason was 11.6 per 100 users at five years. The LNG-IUDs removed for investigation after five years of use revealed that the devices contained about 40 percent of the original load. The effective lifespan of the device has been demonstrated by this study to be five years; the residual steroid gives an additional safety period of two more years. The LNG-IUD is a highly effective reversible contraceptive method, which strongly reduced the amount and duration of bleeding. During the first two months there is scanty but frequent spotting which, like the high incidence of oligo- and/or amenorrhea, requires counselling of health personnel and women using LNG-IUDs.

摘要

在一项为期五年的随机对照研究中,对两种释放左炔诺孕酮的宫内节育器(IUD)和一种形状相同的释放铜的IUD进行了研究。释放左炔诺孕酮的IUD每天释放20微克或30微克。在使用左炔诺孕酮宫内节育器的10600妇女-月期间,Pearl指数为0.11。对照的释放铜的器械Pearl指数为1.6。月经出血量和持续时间大大减少,导致月经过少或闭经的发生率很高。在这项开创性试验中,释放左炔诺孕酮的IUD(LNG-IUD)的继续使用率为每100名使用者中有53人,释放铜的IUD(Nova T)为每100名使用者中有50人。因闭经以外的原因取出率无显著差异。因闭经而停用发生在头两年,五年时因该原因的累积终止率为每100名使用者中有ll.6人。使用五年后取出用于研究的LNG-IUD显示,器械中含有约40%的原始药量。本研究证明该器械的有效寿命为五年;残留的甾体提供了另外两年的安全期。LNG-IUD是一种高效的可逆避孕方法,能显著减少出血量和持续时间。在头两个月有少量但频繁的点滴出血,与月经过少和/或闭经的高发生率一样,这需要对使用LNG-IUD的卫生人员和妇女进行咨询。

相似文献

1
Five years' experience with levonorgestrel-releasing IUDs.左炔诺孕酮宫内节育器的五年使用经验。
Contraception. 1986 Feb;33(2):139-48. doi: 10.1016/0010-7824(86)90080-6.
2
Long-term contraception with the levonorgestrel 20 mcg/day (LNg 20) and the copper T 380Ag intrauterine devices: a five-year randomized study.左炔诺孕酮20微克/天(LNG 20)和铜T 380Ag宫内节育器的长期避孕效果:一项为期五年的随机研究。
Contraception. 1990 Oct;42(4):361-78. doi: 10.1016/0010-7824(90)90046-x.
3
Two years of intrauterine contraception with levonorgestrel and with copper: a randomized comparison of the TCu 380Ag and levonorgestrel 20 mcg/day devices.左炔诺孕酮与铜宫内节育两年:TCu 380Ag与左炔诺孕酮20微克/天装置的随机对照比较。
Contraception. 1987 Mar;35(3):245-55. doi: 10.1016/0010-7824(87)90026-6.
4
Hormonal intrauterine devices.激素宫内节育器
Ann Med. 1993 Apr;25(2):143-7. doi: 10.3109/07853899309164158.
5
Effective contraception with the levonorgestrel-releasing intrauterine device: 12-month report of a European multicenter study.左炔诺孕酮宫内节育器的有效避孕:一项欧洲多中心研究的12个月报告。
Contraception. 1987 Aug;36(2):169-79. doi: 10.1016/0010-7824(87)90012-6.
6
Acceptability of an experimental intracervical device: results of a study controlling for selection bias.一种实验性子宫颈内装置的可接受性:一项控制选择偏倚研究的结果
Contraception. 1989 Jan;39(1):73-84. doi: 10.1016/0010-7824(89)90016-4.
7
An evaluation of the levonorgestrel-releasing IUD: its advantages and disadvantages when compared to the copper-releasing IUDs.左炔诺孕酮宫内节育器评估:与含铜宫内节育器相比的优缺点。
Contraception. 1991 Dec;44(6):573-88. doi: 10.1016/0010-7824(91)90078-t.
8
Two years' experience with two levonorgestrel-releasing intrauterine devices and one copper-releasing intrauterine device: a randomized comparative performance study.两种左炔诺孕酮宫内节育器和一种含铜宫内节育器的两年使用经验:一项随机对比性能研究。
Fertil Steril. 1983 Feb;39(2):187-92.
9
Levonorgestrel-releasing IUD as a method of contraception with therapeutic properties.左炔诺孕酮宫内节育器作为一种具有治疗特性的避孕方法。
Contraception. 1995 Nov;52(5):269-76. doi: 10.1016/0010-7824(95)00210-2.
10
Levonorgestrel-releasing and copper-releasing (Nova T) IUDs during five years of use: a randomized comparative trial.左炔诺孕酮释放型和铜释放型(Nova T)宫内节育器五年使用情况:一项随机对照试验
Contraception. 1994 Jan;49(1):56-72. doi: 10.1016/0010-7824(94)90109-0.

引用本文的文献

1
Impact of drug loading on release from levonorgestrel intrauterine systems.药物载量对左炔诺孕酮宫内节育系统释放的影响。
Int J Pharm. 2023 Jan 25;631:122532. doi: 10.1016/j.ijpharm.2022.122532. Epub 2022 Dec 21.
2
Utility of the Levonorgestrel-Releasing Intrauterine System in the Treatment of Abnormal Uterine Bleeding and Dysmenorrhea: A Narrative Review.左炔诺孕酮宫内节育系统在治疗异常子宫出血和痛经中的应用:一项叙述性综述。
J Clin Med. 2022 Oct 1;11(19):5836. doi: 10.3390/jcm11195836.
3
Levonorgestrel-Releasing Intrauterine System Use in Perimenopausal Women.
左炔诺孕酮宫内缓释系统在围绝经期妇女中的应用
J Menopausal Med. 2021 Aug;27(2):49-57. doi: 10.6118/jmm.20038.
4
Thirty years of mirena: A story of innovation and change in women's healthcare.三十载米乐娜:妇女生殖健康领域的创新与变革。
Acta Obstet Gynecol Scand. 2021 Apr;100(4):614-618. doi: 10.1111/aogs.14110. Epub 2021 Feb 23.
5
Levonorgestrel intrauterine system associated amenorrhea: a systematic review and metaanalysis.左炔诺孕酮宫内节育系统相关闭经:系统评价和荟萃分析。
Am J Obstet Gynecol. 2019 May;220(5):440-448.e8. doi: 10.1016/j.ajog.2018.12.008. Epub 2018 Dec 7.
6
Intrauterine levonorgestrel delivery with frameless fibrous delivery system: review of clinical experience.使用无框架纤维递送系统进行宫内左炔诺孕酮递送:临床经验回顾
Int J Womens Health. 2017 Jan 21;9:49-58. doi: 10.2147/IJWH.S122579. eCollection 2017.
7
Levonorgestrel-releasing intrauterine systems for long-acting contraception: current perspectives, safety, and patient counseling.左炔诺孕酮宫内缓释系统用于长效避孕:当前观点、安全性及患者咨询
Int J Womens Health. 2016 Oct 13;8:589-598. doi: 10.2147/IJWH.S99705. eCollection 2016.
8
Safety and efficacy in parous women of a 52-mg levonorgestrel-medicated intrauterine device: a 7-year randomized comparative study with the TCu380A.52毫克左炔诺孕酮宫内节育器在经产妇女中的安全性和有效性:一项与TCu380A进行的7年随机对照研究。
Contraception. 2016 Jun;93(6):498-506. doi: 10.1016/j.contraception.2016.02.024. Epub 2016 Feb 23.
9
Twenty-four-month continuation of reversible contraception.24 个月可逆避孕措施的延续。
Obstet Gynecol. 2013 Nov;122(5):1083-1091. doi: 10.1097/AOG.0b013e3182a91f45.
10
Benefit-risk assessment of the levonorgestrel intrauterine system in contraception.左炔诺孕酮宫内节育系统用于避孕的获益-风险评估。
Drug Saf. 2004;27(15):1185-204. doi: 10.2165/00002018-200427150-00003.